Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Oncology Report

• Publication date

  2015-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2014.3641PMID 25482320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR‐181a mediates TGF‐β‐induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer

  2015cited by this paper
• A two-microRNA signature as a potential biomarker for early gastric cancer

  2014cited by this paper
• MicroRNA-92a as a Potential Biomarker in Diagnosis of Colorectal Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer.

  2014cited by this paper
• miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1

  2013cited by this paper
• Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R

  2013cited by this paper
• Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance

  2013cited by this paper
• MiR‐150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1

  2013cited by this paper
• Epigenetic regulation of miR‐124 by Hepatitis C Virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3

  2012cited by this paper
• Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.

  2012cited by this paper
• Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type

  2012cited by this paper
• The role of microRNA-150 as a tumor suppressor in malignant lymphoma

  2011cited by this paper
• MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

  2011cited by this paper
• Intrahepatic cholangiocarcinoma: An international, multi-institutional analysis of prognostic factors and lymph node assessment.

  2011cited by this paper
• Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.

  2011cited by this paper
• Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells

  2010cited by this paper
• MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.

  2010cited by this paper
• Comparison of Serum Tumor Markers for Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma

  2010cited by this paper
• Causes and consequences of microRNA dysregulation in cancer

  2009cited by this paper
• Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature.

  2009cited by this paper
• Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.

  2009cited by this paper
• Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.

  2009cited by this paper
• The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma.

  2009cited by this paper
• [Prognosis of 84 intrahepatic cholangiocarcinoma patients].

  2009cited by this paper
• Widespread microRNA repression by Myc contributes to tumorigenesis

  2008cited by this paper
• Surgical Outcome and Prognostic Factors in Intrahepatic Cholangiocarcinoma

  2008cited by this paper
• MicroRNAs miR-186 and miR-150 Down-regulate Expression of the Pro-apoptotic Purinergic P2X7 Receptor by Activation of Instability Sites at the 3′-Untranslated Region of the Gene That Decrease Steady-state Levels of the Transcript*

  2008cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

  2008cited by this paper
• Illuminating the silence: understanding the structure and function of small RNAs

  2007cited by this paper
• Tumour-related microRNAs functions in Caenorhabditis elegans

  2006cited by this paper
• Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.

  2003cited by this paper
• Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer

  2003cited by this paper
• Intrahepatic cholangiocarcinoma. Current management.

  2003cited by this paper
• Worldwide trends in mortality from biliary tract malignancies

  2002cited by this paper
• Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival

  2002cited by this paper
• Liver transplantation for cholangiocellular carcinoma: Analysis of a single‐center experience and review of the literature

  2001cited by this paper
• Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.

  2001cited by this paper
• Liver transplantation for cholangiocarcinoma: results in 207 patients.

  2000cited by this paper

• Cholangiocarcinoma 2026: status quo, unmet needs and priorities

  2025cites this paper
• Precision oncology in biliary tract cancer: the emerging role of liquid biopsy

  2025influential citation
• Advances in Omics-Based Biomarker Discovery for Biliary Tract Malignancy Diagnosis:A Narrative Review.

  2024cites this paper
• Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma: A Review of Prognostic, Predictive, and Diagnostic Markers

  2024cites this paper
• fetArtificial Intelligence in Liver Cancers: Decoding the Impact of Machine Learning Models in Clinical Diagnosis of Primary Liver Cancers and Liver Cancer Metastases.

  2023cites this paper
• Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis

  2023cites this paper
• Noncoding RNA regulation and Oxidative Stress

  2022cites this paper
• Molecular diagnostics and biomarkers in cholangiocarcinoma.

  2022cites this paper
• Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis

  2022cites this paper
• A High-Accuracy Model Based on Plasma miRNAs Diagnoses Intrahepatic Cholangiocarcinoma: A Single Center with 1001 Samples

  2021cites this paper
• Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology

  2021cites this paper
• Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review

  2021cites this paper
• Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic Conundrum

  2021cites this paper
• Circulating microRNAs as biomarkers in bile-derived exosomes of cholangiocarcinoma

  2021cites this paper
• Next-Generation Biomarkers for Cholangiocarcinoma

  2021influential citation
• Liquid biopsy in cholangiocarcinoma: Current status and future perspectives

  2021cites this paper
• MicroRNA-150 inhibits myeloid-derived suppressor cells proliferation and function through negative regulation of ARG-1 in sepsis.

  2021cites this paper
• Sodium butyrate ameliorates non‐alcoholic fatty liver disease by upregulating miR‐150 to suppress CXCR4 expression

  2021cites this paper
• Cholangiocarcinoma 2020: the next horizon in mechanisms and management

  2020cites this paper
• Pathogenetic Role and Clinical Implications of Regulatory RNAs in Biliary Tract Cancer

  2020cites this paper
• The association between circulating MicroRNA‐150 level and cholangiocarcinoma

  2020cites this paper
• Identification of Prognostic Markers in Cholangiocarcinoma Using Altered DNA Methylation and Gene Expression Profiles

  2020cites this paper
• Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma

  2020cites this paper
• Enhanced plasma miR-142-5p promotes the progression of intrahepatic cholangiocarcinoma via targeting PTEN.

  2019cites this paper
• Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

  2019cites this paper
• Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis

  2019cites this paper
• Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies

  2019cites this paper
• Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells

  2019cites this paper
• LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p.

  2019cites this paper
• Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy

  2019cites this paper
• Circulating Biomarkers for Cholangiocarcinoma

  2018cites this paper
• Modulating Hallmarks of Cholangiocarcinoma

  2018cites this paper
• Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications

  2018cites this paper
• Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis

  2018cites this paper
• The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.

  2017cites this paper
• Role of circulating microRNAs in liver diseases

  2017cites this paper
• Identification of microRNAs as biomarkers for cholangiocarcinoma detection: A diagnostic meta-analysis.

  2017cites this paper
• Gene alterations and epigenetic changes in intrahepatic cholangiocarcinoma

  2017cites this paper
• miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.

  2017cites this paper
• Letter to the editor regarding “Prognostic role of microRNA-150 in various carcinomas: a meta-analysis”

  2017cites this paper
• MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.

  2017cites this paper
• Pronostic du cholangiocarcinome intrahépatique réséqué

  2017cites this paper
• Exosomes in bile as potential pancreatobiliary tumor biomarkers

  2017cites this paper
• Emerging molecular targets and therapy for cholangiocarcinoma

  2017cites this paper
• Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy

  2017cites this paper
• MicroRNA-150 as a Potential Biomarker in Diagnosis of Cancer: a Meta-Analysis.

  2017cites this paper
• MicroRNAs and extracellular vesicles in cholangiopathies.

  2017cites this paper
• MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.

  2016cites this paper
• Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers

  2016cites this paper
• Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers

  2016influential citation
• The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer

  2016cites this paper
• The role of microRNAs in intrahepatic cholangiocarcinoma

  2016cites this paper
• Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma

  2016cites this paper
• A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment

  2016cites this paper
• Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison

  2016cites this paper
• Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy.

  2016cites this paper
• Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis

  2015cites this paper
• A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma

  2015cites this paper
• miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT

  2015cites this paper